← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Baystate Medical Center, Inc.
Springfield, MA
$64,685,181
Total funding
49
Grants
Funding over time
peak $7.9M · FY2006–25$10M$7.5M$5M$2.5M$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$58,774,377 · 40
AHRQ$4,092,762 · 7
DOD$1,818,042 · 1
SAMHSA$0 · 1
By mechanism
R01$24,095,787 · 13
UG1$9,047,644 · 1
UH3$3,920,511 · 1
R33$3,200,137 · 1
N01$3,078,003 · 1
R18$3,077,588 · 2
Investigators at Baystate Medical Center, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Largest grants
Massachusetts Justice Community Opioid Innovation Network (JCOIN) Clinical Research Center$2,172,667
UG1 · FY2020 · DA
Massachusetts Justice Community Opioid Innovation Network (JCOIN) Clinical Research Center$2,120,889
UG1 · FY2021 · DA
Massachusetts Justice Community Opioid Innovation Network (JCOIN) Clinical Research Center$2,086,717
UG1 · FY2019 · DA
Massachusetts Justice Community Opioid Innovation Network (JCOIN) Clinical Research Center$2,073,692
UG1 · FY2022 · DA
PVLSI BREAST CANCER RESEARCH PROGRAM: BIOMARKERS AND CHEMOPREVENTION$1,818,042
· FY2008 · Department of Defense
Drug Injection Surveillance and Care Enhancement for Rural Northern New England (DISCERNNE)$1,410,784
UH3 · FY2020 · DA
Drug Injection Surveillance and Care Enhancement for Rural Northern New England (DISCERNNE)$1,377,991
UH3 · FY2019 · DA
Treatment of Acute Lung Injury and Acute Respiratory Distress Syndrome$1,003,256
N01 · FY2010 · HL
Drug Injection Surveillance and Care Enhancement for Rural Northern New England (DISCERNNE)$983,737
UH3 · FY2021 · DA
Implementation to motivate physician response to opioid dependence in HIVsetting$769,749
R01 · FY2018 · DA
Implementation to motivate physician response to opioid dependence in HIVsetting$769,194
R01 · FY2015 · DA
A Type I Hybrid Effectiveness-Implementation Trial of "Mothering from the Inside Out" (MIO)$755,576
R01 · FY2024 · DA
Identifying effective strategies used by Medicare Accountable Care Organizations to improve outcomes for patients with heart failure: A mixed-methods study$753,142
R01 · FY2018 · HL
Improving Participation in Pulmonary Rehabilitation through Peer-Support and Storytelling$751,646
R61 · FY2021 · HL
Identifying effective strategies used by Medicare Accountable Care Organizations to improve outcomes for patients with heart failure: A mixed-methods study$739,651
R01 · FY2019 · HL
Implementing Effective Smoking Cessation Pharmacotherapy for Hospitalized Smokers with Cardiopulmonary Disease$736,010
R01 · FY2022 · HL
Improving Participation in Pulmonary Rehabilitation through Peer-Support and Storytelling$722,784
R33 · FY2022 · HL
A Type I Hybrid Effectiveness-Implementation Trial of "Mothering from the Inside Out" (MIO)$717,691
R01 · FY2025 · DA
Impact of health reform on outpatient substance abuse treatment programs$708,258
R01 · FY2016 · DA
A mixed methods study to analyze the use of pulmonary rehabilitation following hospitalization for COPD, and to identify effective strategies for increasing rates of participation$703,217
R01 · FY2020 · HL